The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering?
作者信息
Purnhagen Kai P
机构信息
University of Lucerne, Switzerland.
出版信息
Food Drug Law J. 2008;63(3):623-45.
PMID:19031663
Abstract
摘要
相似文献
1
2
The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.制药行业在发展中国家传播药物警戒实践中的作用。
Food Drug Law J. 2008;63(3):701-11.
3
4
Shifting terrain in the regulation of off-label promotion of pharmaceuticals.药品未标示用途推广监管方面不断变化的形势。
N Engl J Med. 2009 Apr 9;360(15):1557-66. doi: 10.1056/NEJMhle0807695.
5
6
The ongoing regulation of generic drugs.仿制药的持续监管。
N Engl J Med. 2007 Nov 15;357(20):1993-6. doi: 10.1056/NEJMp078193.
7
Drug safety reform at the FDA--pendulum swing or systematic improvement?美国食品药品监督管理局的药物安全改革——是钟摆摆动还是系统性改进？
N Engl J Med. 2007 Apr 26;356(17):1700-2. doi: 10.1056/NEJMp078057. Epub 2007 Apr 13.
8
Drug regulation 2056.药品监管2056年。
Food Drug Law J. 2005;60(2):127-36.
9
Access before approval--a right to take experimental drugs?批准前获取——有权使用实验性药物？
N Engl J Med. 2006 Aug 3;355(5):437-40. doi: 10.1056/NEJMp068132.
10
Paying for drug approvals--who's using whom?为药物审批付费——谁在利用谁？
N Engl J Med. 2007 Apr 26;356(17):1697-700. doi: 10.1056/NEJMp078041. Epub 2007 Apr 13.
Zotero 插件